Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer

ClinicalTrials.gov ID: NCT04869943

Public ClinicalTrials.gov record NCT04869943. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Crossover Ph3 to Evaluate Efficacy/Safety of Enobosarm Monotherapy vs Active Control for Treatment of AR+/ER+/HER2- MBC With AR Staining Previously Treated w/Nonsteroidal Aromatase Inhibitor, SERD & CDK 4/6 Inhibitor

Study identification

NCT ID
NCT04869943
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Veru Inc.
Industry
Enrollment
52 participants

Conditions and interventions

Interventions

  • Enobosarm Drug
  • Exemestane Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 11, 2021
Primary completion
Jan 8, 2024
Completion
Jan 8, 2024
Last update posted
Jan 25, 2024

2021 – 2024

United States locations

U.S. sites
34
U.S. states
17
U.S. cities
32
Facility City State ZIP Site status
Ironwood Cancer and Research Centers Chandler Arizona 85224
Banner Health/ Banner MD Anderson Cancer Center Gilbert Arizona 85234
The Oncology Insitute of Hope and Innovation Glendale California 91204
Marin Cancer Care, Inc. Greenbrae California 94904
California Research Institute (CRI) Los Angeles California 90027
University of California San Francisco Comprehensive Cancer Center San Francisco California 94158
Providence Medical Group Santa Rosa California 95043
Rocky Mountain Cancer Centers Denver Colorado 81008
Morton Plant Hospital/ BayCare Health System, Inc Clearwater Florida 33756
University of Miami- Sylvester Comprehensive Cancer Center Miami Florida 33146
Miami Cancer Institute Miami Florida 33176
Woodlands Medical Specialists, PA Pensacola Florida 32503
Miami Cancer Institute, Plantation MCIP Plantation Florida 33324
University Cancer & Blood Center Athens Georgia 30607
Blessing Corporate Services Quincy Illinois 62301
MBCCOP - LSU Health Sciences Center Shreveport Louisiana 71103
Dana-Farber Cancer Institute Breast Oncology Boston Massachusetts 02215
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169
Astera Cancer Care East Brunswick New Jersey 08816
Inspira Medical Center Mullica Hill Mullica Hill New Jersey 08062
Inspira Medical Center Vineland New Jersey 08360
The Lindner Center for Research and Education at the Christ Hospital Cincinnati Ohio 45219
Magee-Women's Hospital Pittsburgh Pennsylvania 15219
Tidelands Health Murrells Inlet South Carolina 29576
Tennessee Cancer Specialists Knoxville Tennessee 37909
Baptist Clinical Research Institute Nashville Tennessee 38102
Texas Oncology Sammons Cancer Center Dallas Texas 75246
Texas Oncology - Tyler Tyler Texas 75702
Virginia Cancer Specialists Fairfax Virginia 22031
Virginia Oncology Associates Norfolk Virginia 23502
Oncology and Hematology Associates of Southwest Virginia, Inc. Roanoke Virginia 24014
MultiCare Institute for Research and Innovation Puyallup Washington 98372
Cancer Care Northwest Spokane Washington 99216
MultiCare Institute for Research and Innovation Spokane Washington 99218

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04869943, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 25, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04869943 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →